Lipiodol Ultra-Fluide (Ethyl Esters Of Iodised Fatty Acids From Poppyseed Oil)

The active ingredient, ethyl esters of iodised fatty acids from poppyseed oil, contains a high density of iodine atoms. Iodine strongly absorbs X‑ray photons, creating a radiopaque image. When the oil is introduced into the lymphatic or vascular system, it remains localized, outlining the anatomy and improving contrast on fluoroscopic or CT scans.

The dosage of Lipiodol Ultra-Fluide is determined by the prescribing physician based on the specific imaging study, patient size, and clinical indication. The prescriber selects the appropriate volume and concentration to achieve optimal contrast while minimizing exposure.

Safety data for Lipiodol Ultra-Fluide in pregnancy and lactation are limited. Because the product contains iodine, which can affect fetal thyroid function, it should be used only if clearly needed and after a risk‑benefit assessment by the healthcare provider. Breastfeeding mothers should consult their physician before exposure.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lipiodol Ultra-Fluide is an oil‑based, iodine‑rich formulation that remains within the lymphatic or vascular compartment longer than water‑soluble contrast media, making it especially useful for lymphangiography and embolization. Compared with aqueous agents, it provides prolonged imaging windows but may have a higher risk of oil‑related adverse events, requiring careful patient selection.

Lipiodol Ultra-Fluide should be stored at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from moisture, direct sunlight and extreme temperatures. Do not freeze the product, and ensure the container is sealed to prevent contamination.

The product is administered by a qualified healthcare professional via intralymphatic injection. The sterile oil is injected directly into the targeted lymphatic channel or vascular bed under imaging guidance. Proper aseptic technique and real‑time monitoring are essential to ensure accurate delivery and patient safety.

Serious risks include severe hypersensitivity reactions such as anaphylaxis, pulmonary embolism from oil migration, contrast‑induced nephropathy, and cardiovascular collapse. Immediate medical intervention is required if any of these events occur. Patients should be monitored closely during and after administration.

Patients with a known allergy to iodine‑containing contrast agents, uncontrolled hyperthyroidism, severe renal impairment, or those who have had prior severe reactions to oil‑based contrast media should generally avoid Lipiodol Ultra-Fluide. The prescribing clinician must evaluate each individual’s medical history before use.